Results-Among the 347 patients (occlusion sites: middle cerebral artery=200, 58%; internal carotid artery Siphon=89, 25%; Tandem=58, 17%), aspiration component led to successful reperfusion (modified thrombolysis in cerebral infarction 2b/3 scores) in 55.6% (193/347 patients), stent retrievers were required in 40%, and a total successful final reperfusion rate of 83% (288/347) was achieved. Overall, procedural complications occurred in 13.3% of patients (48/347). Modified Rankin Scale score of 0 to 2 at 90 days was reported in 45% (144/323). Only 2 factors positively influenced the success of the aspiration component: an isolated middle cerebral artery occlusion (P<0.001) and a shorter time from stroke onset to clot contact (P=0.018). Conclusions-In this large retrospective study, ADAPT was shown to be safe and effective for anterior circulation acute ischemic stroke with a final successful reperfusion achieved in 83%. The site of arterial occlusion and delay of the procedure were predictors for reperfusion. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT02523261, NCT02678169, and NCT02466893.
R
ecent randomized controlled trials have demonstrated the benefit of mechanical thrombectomy (MT) in combination with intravenous tissue-type plasminogen activator in treatment of acute ischemic stroke (AIS) consecutive to large vessel occlusion. [1] [2] [3] A direct aspiration first pass technique (ADAPT) for the endovascular treatment of stroke using large-bore aspiration catheters was reported to be an effective method of MT for stroke therapy. 4 This technique involves direct first-pass thrombus aspiration alone (aspiration component) and when needed use of an adjunctive therapy such as stent retriever (SR) introduced through the large-bore aspiration catheter to achieve reperfusion. Recent studies reported a total reperfusion rate after ADAPT ranging from 75% to 94%, the aspiration component alone being successful in 53% to Background and Purpose-A direct aspiration first pass technique (ADAPT) has been reported to be fast, safe, and effective for the treatment of acute ischemic stroke. The aim of this study is to determine the preoperative factors that affect success of the aspiration component of the technique in ischemic stroke patients with large vessel occlusion in the anterior circulation. Methods-We enrolled all 347 consecutive patients with anterior circulation acute ischemic stroke admitted for mechanical thrombectomy at our institution from August 2013 to October 2015 and treated by ADAPT for the endovascular treatment of stroke. Baseline and procedural characteristics, modified thrombolysis in cerebral infarction scores, and 3-month modified Rankin Scale were captured and analyzed.
78%. [4] [5] [6] [7] [8] [9] [10] [11] [12] We aimed to identify patients in whom the aspiration component of ADAPT is most likely to be successful.
Materials and Methods

Standard Protocol Approvals
The use of patient data for this retrospective study was approved by the relevant local ethics committee and by the Commission Nationale de l'Informatique et des Libertés.
Patients
On the basis of a prospectively gathered database of patients with AIS treated at 1 single comprehensive French stroke center, data were extracted from patients admitted for endovascular MT from August 2013 to October 2015 and for whom ADAPT was used as the frontline MT option. Patients referred for AIS consecutive to vertebrobasilar occlusion were excluded. At admission, most patients underwent preferentially brain magnetic resonance (MR) imaging and MR angiography. In cases of MR imaging contraindication, brain computed tomography (CT) scan and CT angiography were performed. Patients with low Alberta Stroke Program Early CT score of ≤6 were not excluded.
Data Collection and Definitions
Patient demographics, National Institutes of Health Stroke Scale (NIHSS) at presentation, arterial occlusion site and lateralization, diffusion-weighted images-Alberta Stroke Program Early CT Score, intravenous thrombolysis before MT, angiographic, and clinical data were collected. AIS severity was assessed using NIHSS at admission and 24 hours later. The clot burden score (based on MR T2*) was assessed as well. 13 A favorable functional outcome was defined as a 90-day modified Rankin Scale (mRS) score of ≤2. All patients had a Flat-Panel CT at the end of the procedure and a CT or MR imaging scan 24 hours after treatment onset to assess hemorrhagic complications. Symptomatic intracranial hemorrhage was defined as parenchymal hematoma type 2 using the ECASS III grading (European Cooperative Acute Stroke Study) according to imaging at 24 hours, associated with an increase of at least 4 NIHSS points within 24 hours, or resulting in death. 14 Time from symptom onset (or from patient last seen normal) to femoral puncture was recorded. The tortuosity on the path of the target vessel (number of reverse curves) was recorded. 15 During the MT procedure, the number of passes with the aspiration device, the needs for second-line device, and their type were collected. Embolic complications were assessed such as embolization in the same territory, defined as an occlusion in a previously unaffected downstream vascular territory observed on the angiogram after clot removal, or of a new territory (embolus in new territory), defined as an occlusion in a previously unaffected nondownstream vascular territory observed on the angiogram after clot removal. Cervical artery dissection, arterial perforation during navigation of the devices, and postoperative subarachnoid hemorrhage visible on Flat-Panel CT were also collected. 16 Time from femoral puncture to clot contact and to reperfusion assessed by the final control angiogram were also recorded.
Outcome Measures
The primary outcome was the rate of successful reperfusion (modified thrombolysis in cerebral infarction [mTICI] score of 2b or 3) after the use of aspiration component 16, 17 ; secondary outcomes included rate of final successful reperfusion, safety issues (procedural complications), procedural times (onset and femoral puncture to reperfusion), favorable outcome defined by a mRS score of 0 to 2 at 3-month (performed by an independent senior vascular neurologists during face-to-face interviews or via telephone conversations) and 90-day all-cause mortality.
Endovascular Procedure
Patients presenting within 4.5 hours of AIS symptom onset consecutive to anterior circulation large vessel occlusion were eligible for combined therapy of intravenous fibrinolysis 18 followed by adjunctive MT (bridging therapy). Stand-alone thrombectomy was indicated in cases of contraindication of intravenous tissue-type plasminogen activator in accordance with ECASS III trial results. 18 ADAPT was implemented as described in detail previously. 4, 6 Briefly, a large-bore guide catheter such as a Neuron Max 0.088 inches (Penumbra Inc, Alameda, CA) was placed distally into the internal carotid artery followed by the aspiration catheter (Penumbra ACE or ACE64) which was advanced at the thrombus surface, usually over a microcatheter and micro guidewire. Aspiration was applied, and either the clot was ingested within the catheter or was affixed at the catheter tip and withdrawn under continuous vacuum exerted by a dedicated aspiration pump. If aspiration alone failed, access was maintained through the large-bore aspiration catheter, and then second-line option was considered with the use of an SR at the operator's discretion. A control angiogram was performed to confirm reperfusion. This sequence was repeated until modified thrombolysis in cerebral infarction 2b or 3 flow was achieved.
Statistical Analysis
Continuous variables are expressed as means±SD or medians (interquartile range), and qualitative variables are expressed as numbers (percentage). Normality of distributions was assessed using histograms and Shapiro-Wilk test. To assess the selection bias, we compared the baseline characteristics between included and nonincluded patients using the χ 2 test for qualitative variables and Student t test for continuous variables (or Mann-Whitney U test for non-Gaussian distributions). The magnitude of the between-group differences was assessed by calculating the standardized differences; an absolute standardized differences >0.20 was interpreted as meaningful difference. 19 Bivariate comparisons between successful and unsuccessful reperfusion after the aspiration component and between patients with and without favorable outcome were also made using χ 2 test for qualitative variables and Student t test or Mann-Whitney U test for continuous variables as appropriate.
We investigated the independent predictors of successful reperfusion after the aspiration component of ADAPT using a multivariable logistic regression model. Predictors were considered for application to the multivariable regression analysis irrespective of bivariate comparisons. The full model was simplified with a backward selection procedure by using a removal criteria of P>0.05. Candidate predictors were age, sex, hypertension, diabetes mellitus, dyslipidemia, current smoking, antithrombotic medications, admission NIHSS, diffusion-weighted images-Alberta Stroke Program Early CT Score <7, isolated middle cerebral artery (MCA) occlusion, left side occlusion, cardioembolic stroke, intravenous thrombolysis, general anesthesia, and time from symptom onset to clot contact (log-transformed to reduce the skewness). Before developing the multivariable prognostic model, continuous predictor was categorized using quintiles to examine the log-linearity assumption for continuous predictor. Colinearity between candidates predictors was also examined by calculating the variance inflation factors. To avoid case deletion in multivariable analysis because of missing data on candidate predictors (n=33, 9.5%), missing data were imputed by simple imputation using regression switching approach (chained equations obtained using the R statistical software version 3.03). 20 The imputation procedure was performed using all candidate predictors and successful reperfusion status with predictive mean matching method for continuous variables and logistic regression model for binary variables. A sensitivity analysis using multiple imputation procedure to handle missing data (m=20 imputations) was performed using the Rubin rules to combine the multiple imputed data sets. 21 We examined the performance of the final model in terms of calibration and discrimination. Discrimination (which indicates to what extent the model distinguishes between patients with successful reperfusion after adapt from those without) was evaluated using the C statistics corrected for overoptimism using bootstrap resampling with 200 repetitions. 22 Calibration (which indicates the agreement between the predicted and observed probabilities of unsuccessful reperfusion after ADAPT) was evaluated using the Hosmer-Lemeshow goodness-of-fit test. The same methodology was
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used to investigate the independent predictors of favorable outcome (mRS score of ≤ 2). Statistical testing was done at the 2-tailed α level of 0.05. Data were analyzed using the SAS software package, release 9.3 (SAS Institute, Cary, NC).
Results
From 2013 to 2015, 547 patients were screened for potential endovascular therapy of anterior circulation ischemic stroke, and 472 were treated (75 were not treated endovascularly because of reperfusion before MT or too severe conditions). Among these, 347 were treated with ADAPT as a primary goal and constituted the study sample. Patient's characteristics of study sample are described in Table 1 . Mean age was 66±15 years, and 54% were men. Median time from symptoms onset to clot contact was 283 minutes (interquartile range, 234-354) with median NIHSS score of 17 (interquartile range, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] and a DWI-ASPECT <6 in 33% of cases (115/347 patients). During this period of time, 125 patients treated on intent by SR technique according to the operator's choice or because of the inclusion in a research protocol are not included in this study sample. Compared with included patients, patients treated on intent by SR technique were older and had a more severe stroke at admission (Table I in the online-only Data Supplement).
Procedure Characteristics and Outcomes
Aspiration component was effective in 55.6% (193/347 patients) with a median of 2 passes, within a median time from groin puncture to reperfusion of 37 minutes (interquartile range, 24-54), 4% (16/347) of patient did not achieve TICI 2b/3, and treatment was not pursued. A rescue therapy with an SR was used in 40% (138/347 patients).
Procedural complications occurred in 13.3% of cases (n=41; 95% confidence interval, 16%-25%). Eight nonocclusive carotid dissections at the petrocervical junction were encountered. Twenty-two erratic emboli to new territory were visualized. Five periprocedural subarachnoid hemorrhages (arterial perforation) occurred (3 during the aspiration component of ADAPT). Six postprocedural subarachnoid hemorrhages were detected on the Flat-Panel CT performed immediately after the treatment (1/6 was detected when the aspiration component of ADAPT was the only technique used). Five symptomatic delayed intracerebral hemorrhages (1.8%) were also encountered. Follow-up mRS values at 3 months were available for 323 patients (93%; mean age, 66 years; men, 47%). Among them, good outcome (mRS score of 0-2) was observed in 144 cases (45%), and death occurred in 73 patients (23%).
Predictors of Successful Reperfusion After Aspiration Component of ADAPT
Baseline characteristics according to successful reperfusion after aspiration component are reported in Table 1 . As shown in the Figure, the rate of successful reperfusion was higher in patients with isolated MCA occlusion than in patients with internal carotid artery occlusion (alone or in tandem with MCA) and decreased with quintiles of time from symptom onset to clot contact. In backward stepwise regression analysis, a decrease in time from symptom onset to clot contact and isolated MCA occlusion was independent predictors for successful reperfusion of aspiration first-pass component (Table 2 ). Sensitivity analysis using multiple imputation procedure to handle missing data on candidate predictors found similar results (data not shown). After correction for overoptimism, the discrimination of the selected prognostic model was 0.60 (95% confidence interval, 0.54-0.66) with a good calibration as indicated by the Hosmer-Lemeshow goodness-of-fit test (P=0.13).
Predictors of Favorable Outcome
Bivariate comparisons in baseline characteristics according to favorable outcome at 3 months are available in Table II in the online-only Data Supplement. In backward stepwise regression analysis, age, admission NIHSS score, time from symptom onset to clot contact, general anesthesia, diffusionweighted imaging-Alberta Stroke Program Early CT Score <7, and men were associated with a decrease in favorable rate, whereas as prior use of IV thrombolysis was associated with an increase.
Discussion
After the recent reports from 5 randomized controlled trials demonstrating the superiority of MT over standard medical management alone, attention in the field focuses now on reducing time to reperfusion, optimizing imaging methods for patient selection, and evaluating new MT devices. 23, 24 Because most of these trials involved predominantly the use of SR technology, questions remain on the safety and efficacy of aspiration thrombectomy as a front-line therapy. ADAPT has gained growing acceptance because it is considered to perform fast reperfusion, and probably at a lower cost. 25 Nonetheless, controversies about the relevance of the technique have arisen as in case of aspiration component failure, it might induce a potential delay in reperfusion which could have been avoided using the SR technique and also because this technique does not use a proximal flow arrest with Balloon guide catheter known to prevent embolus in new territory. 26, 27 Although no comparative studies have been conducted with ADAPT versus the validated SR technique, some evidences suggest noninferiority 9 or superiority of the ADAPT technique to achieve better reperfusion rates. 7 In this perspective, more insights are needed to identify which patients may benefit from this technique.
In the first study evaluating ADAPT, 98 patients were included at 6 centers. An impressive 95% successful reperfusion rate (TICI perfusion scale grade 2b/3) was achieved, the time to reperfusion was 37 minutes, and the aspiration component alone was able to achieve TICI 2b/3 in 78%. 4 In this study, favorable outcomes (defined by a mRS score of 0-2) at 90 days were observed in 40% of the cases and a mortality rate of 20%. Another European single-center study, 6 including 54 patients, showed a 93% successful reperfusion rate achieved within a time to reperfusion of 30 minutes; aspiration alone being successful in 56%. Similarly, Vargas et al 11 reported their long-term experience with ADAPT in 191 patients with reperfusion rates (TICI 2b) of 94.2%; the aspiration component of the technique being effective in 76%. These findings parallel those from our study. Overall, in our population, including all the cases of on intent ADAPT, a rate of successful revascularization was achieved in 83% of patients. The median time 
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from puncture to reperfusion of 45 minutes when aspiration component alone was successful and 61 minutes overall (81 minutes when SR were required) with acceptable complication rates. The other major findings of this study are that an MCA occlusion and a shorter stroke onset to clot contact time are predictors of successful reperfusion with the aspiration component of ADAPT. These findings were not reported in previous studies evaluating this approach. 4, 6, 12 Better results for MCA thrombus location might be explained by an optimal vessel size and aspiration catheter diameter ratio. One can anticipate that smaller diameter clots lodge into smaller vessels (ie, MCA location), which correspond better to the catheter diameter (easier ingestion of the clot or better affixing of the proximal surface of the clot retrievability). Previous studies have already found that the probability of thrombus lysis after intravenous tissue-type plasminogen activator infusion is associated with its location, size, and type and with the collateral status. [28] [29] [30] Other studies suggested that the probability of a successful reperfusion after MT was also associated with thrombus location 31 and type. 32 To our knowledge, no previous study found any association between time delay and successful reperfusion after MT. A recent study suggested that a thrombus within the intracranial artery could have 2 components, that is, the original embolus and de novo fresh thrombus formation around this original thrombus. 33 This de novo thrombus formation around the causal embolus is probably a time-dependent phenomenon, associated with thrombus burden and poor collateral status (blood stasis). We may consider that this de novo thrombus formation could preclude a successful impaction of the embolus into the aspiration catheter avoiding its retrievability. Another hypothesis to explain these findings would be the occurrence of biological interactions between the thrombus and the arterial wall leading to specific and firm adhesion responsible for resistance to mechanical retraction. But this hypothesis has never been explored in in vitro and in vivo experimental models.
We were not able to find in our experience a relationship between aspiration component success and younger age of the patients as in a recent article. 12 Neither were we able to demonstrate a relationship with clot cause. We demonstrate a total rate of periprocedural embolus in new territory of 6%. These rates of embolic complications are within the range of previous reports either in vitro or on patients' cohorts. 26 Improvements of the technique especially with development of larger less traumatic, with better trackability catheters, to decrease the needs for SR are required. Improvements in logistics, with patients more rapidly in the odds ratio, could have an impact on the efficacy of the aspiration component technique.
Limitations of this study include its retrospective study design, the unblinded approach to the evaluation of modified thrombolysis in cerebral infarction scores, which were selfreported rather than adjudicated by a core imaging laboratory. In addition, we cannot exclude a selection bias of patients treated by ADAPT as primary goal because of operator's choice or inclusion in an SR research protocol since by comparison to ADAPT-treated patients, patients treated on intent by SR technique were older and were admitted with more severe stroke. Because most of our patients were explored by nonenhanced MR imaging, we were not able to assess the collateral score and include this potential confounder in our multivariate logistic regression analyses.
Although the aspiration is already widely used, up to now there is no evidence for the effectiveness of aspiration. In THERAPY trial (The Randomized, Concurrent Controlled Trial to Assess the Penumbra System's Safety and Effectiveness in the Treatment of Acute Stroke), 34 although there was a significant shift in mRS, this was a predefined secondary outcome and not a primary outcome. Thus, evaluation of efficacy and cost-effectiveness of aspiration and then SR versus SR alone or Solumbra technique are still necessary. Future studies with independent core imaging to further support those findings are warranted and are currently ongoing through randomized, controlled, multicentric, blinded-end point studies.
Summary
Using ADAPT, >55% of patients may be successfully reperfused with a first-pass direct aspiration, faster than by conventional approaches, and with similar favorable outcome rates. The aspiration component of the technique was most effective in cases of isolated MCA occlusion ischemic strokes with shorter delays of onset. In the future, the evaluation of the relevance of ADAPT versus other treatment modalities is warranted in a randomized study.
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